Search for: "CELGENE" Results 41 - 60 of 183
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Sep 2019, 6:31 am by Deb Givens
Bristol-Myers Squibb’s $74 billion buyout of Celgene Corp. and AbbVie Inc. [read post]
20 Sep 2019, 10:16 am by Alaric Dearment - MedCity News
Nine senators sent a letter to FTC Chairman Joseph Simons urging greater scrutiny over like the one between BMS and Celgene, expressing concern over antitrust issues, innovation and drug pricing. [read post]
12 Sep 2019, 5:44 pm by Doyle, Barlow & Mazard PLLC
Francis Rooney (R-FL) wrote a letter to the FTC, urging the agency to investigate Bristol-Myers Squibb Company’s (“Bristol-Myers”) acquisition of Celgene Corporation (“Celgene”). [read post]
28 Aug 2019, 12:28 pm by Lawrence B. Ebert
Cir. 2016). (...)In any event, even if Arthrex’s patent had issued priorto the passage of the AIA, our court recently rejected arguments similar to Arthrex’s in Celgene Corp. v. [read post]
7 Aug 2019, 2:15 pm by Matthew Rizzolo
Since the Supreme Court upheld the constitutionality of inter partes review (IPR) a little more than a year ago in Oil States, several patent owners have brought other constitutional challenges to America Invents Act (AIA) trial proceedings. [read post]
7 Aug 2019, 2:15 pm by Matthew Rizzolo
But early last week, the Federal Circuit for the first time addressed the applicability of the Takings Clause of the Fifth Amendment to IPRs, holding in Celgene Corp. v. [read post]
5 Aug 2019, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit affirmed a determination by the Patent Trial and Appeal Board (PTAB) that two patents owned by Celgene Corp. were invalid in Celgene Corp. v. [read post]
2 Aug 2019, 9:43 am by IPWatchdog
This week in Other Barks & Bites: The Federal Circuit issues several precedential decisions, including one reviving the patent claims in VirnetX and another determining that America Invents Act (AIA) validity trials don’t violate the Fifth Amendment’s Takings Clause in Celgene. [read post]
2 Aug 2019, 9:43 am by IPWatchdog
This week in Other Barks & Bites: The Federal Circuit issues several precedential decisions, including one reviving the patent claims in VirnetX and another determining that America Invents Act (AIA) validity trials don’t violate the Fifth Amendment’s Takings Clause in Celgene. [read post]
15 Jul 2019, 8:09 am by Michael Geist
Technology transfer in the university context has emerged as significant policy issue with governments seeking to maximize the benefits of public investment in research at Canadian universities. [read post]
17 Mar 2019, 7:48 pm by Juvan Bonni
Court Rejects Alvogen’s Patent Challenge for Celgene’s Cancer Drug (Source: Yahoo Finance) Megan Rose Dickey: BlackBerry Sues Twitter for Patent Infringement (Source: Tech Crunch) Richard Borsuk, Christopher Cushing and Jonathan Oatis: Foxconn Rejects Microsoft Patent Lawsuit, Says Never Had to Pay Royalties (Source: Reuters) Brian Heater: Google Filed a Folding Phone Patent Application, Too (Source: Tech Crunch) Source: WIPO Commentary and Journal Articles: Atty.… [read post]